REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Intron Bio Technology Inc. (South Korea)

Main Activities: Chemical Manufacturing
Full name: Intron Bio Technology Inc. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

iNtRON Biotechnology, Inc specializes in the development of new drugs and diagnostic kit production, and operates globally with a growing number of employees. It is divided into new pharmacies and DRparts, leading the business in the bacteriophage sector. iNtRON Biotechnology, Inc. offers products such as Botox replacement new materials and diagnostic kits.

Headquarters
701~ 704 5Th Joongang Induspia, 138-6 Sangdaewon, Jongwon, Seongnam
Seongnam; Gyeonggi; Postal Code: 462-120

Contact Details: Purchase the Intron Bio Technology Inc. report to view the information.

Website: http://www.intron.co.kr

Basic Information
Total Employees:
Purchase the Intron Bio Technology Inc. report to view the information.
Outstanding Shares:
Purchase the Intron Bio Technology Inc. report to view the information.
Registered Capital:
Purchase the Intron Bio Technology Inc. report to view the information.
Financial Auditors:
Purchase the Intron Bio Technology Inc. report to view the information.
Incorporation Date:
January 18, 1999
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
18.66%
Purchase this report to view the information.
2.05%
Purchase this report to view the information.
1.02%
Purchase this report to view the information.
0.2%
Purchase this report to view the information.
0.07%
Subsidiaries
Intodeworld
Intodeworld Inc
Company Performance
Financial values in the chart are available after Intron Bio Technology Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-12.1%▼
Total operating revenue
-17.62%▼
Operating profit (EBIT)
-7.03%▼
EBITDA
2.48%▲
Net Profit (Loss) for the Period
N/A
Total assets
-31.63%▼
Total equity
-9.68%▼
Operating Profit Margin (ROS)
-10.8%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-21.56%▼
Quick Ratio
38.97%▲
Cash Ratio
26.84%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo